- Rating
- 4(+2)
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper presents an optimal transport based trajectory inference algorithm, which can incorporate directional biological preference based on Finsler geometry. It allows the dynamics model to consider biological prior knowledge such as RNA velocity and lineage tree. These leads to more faithful dynamics modeling.
Critical strengths
1.I find the use of Finsler geometry to incorporate directional prior information both elegant and novel.
2.To the best of my knowledge, how to incorporate biological knowledge into the dynamics modeling is a central and critical problem in trajectory inference. I believe this paper is trying to address a good and hard problem, and its method makes lots of sense theoretically.
Critical weaknesses
1.Some definitions are missing, and some details of algorithm implementation and datasets are missing, which makes the paper harder to follow.
2.The real world data experiments are seem inappropriate. I suspect whether its real world data experiments support their claims.
See questions for details.
Questions for authors
Questions on the mathematical and technical details
-
Although this may seem obvious, it would be helpful to explicitly state that the quantity defined in Eq. (9) (I am not sure what the appropriate terminology is, so let us call it "length" for now) is nonnegative. This is important because this quantity is squared in the definition of the OT cost in Eq. (7). For example, if this quantity could take negative values, squaring it in Eq. (7) would destroy the directional preference induced by the Finsler structure.
-
The conditional path defined in Eq. (11) appears to be very high-dimensional. Does its optimization suffer from the curse of dimensionality? Approximately how much computational time is required to optimize this term?
-
How is the Finsler cost in Eq. (13) computed in practice? Do the authors perform numerical integration for every pair of data points?
-
Based on Eq. (6), I would expect the drift term of the SDE on line 364 to contain only the first two terms. Where does the additional term involving the divergence of come from?
-
What is the "sampling floor" mentioned on line 390? I could not find its definition in either the main text or the appendix.
Major Concerns
My major concerns are as follows.
1. The validity of the temporal information used in the real-data experiments.
To the best of my knowledge, all cells in the Pancreas dataset (Bastidas-Ponce et al., 2019) used in this paper were collected at the same developmental time point (E15.5). What, then, do the three time points in the paper actually represent? I believe that applying the proposed method to single-time-point data is conceptually inappropriate.
A similar issue arises with the erythroid dataset. Although this dataset does contain multiple time points, it is clear from the scVelo documentation that the actual temporal labels do not correspond to the three time points presented in the paper.
The authors should provide a detailed description of these real-world datasets in the appendix, particularly explaining how the temporal labels were constructed and what they represent.
2. Potential data leakage through RNA velocity.
I also noticed that both the Pancreas and erythroid datasets were obtained from scVelo (see below). The paper states that RNA velocity information can be incorporated when working with real-world data. However, RNA velocity estimation methods such as scVelo generally rely on the spliced and unspliced counts of the entire cell population, rather than treating each cell independently. I am therefore seriously concerned that incorporating RNA velocity may introduce data leakage. The authors should clarify how RNA velocity was estimated and whether information from the evaluation data was used during this process.
Overall Assessment
I have no major concerns regarding the proposed model, mathematical formulation, or technical details. In fact, I find the use of Finsler geometry to incorporate directional prior information both elegant and novel.
However, for the reasons outlined above, I am concerned that the real-world experiments do not adequately support the paper's claims and may involve some fundamental methodological issues.
If I have misunderstood any aspect of the experimental setup, I would appreciate clarification from the authors, and I would be willing to raise my rating accordingly. Otherwise, I believe that the real-world experiments should be conducted again on more appropriate datasets.
Data source
Pancreas: https://scvelo.readthedocs.io/en/stable/scvelo.datasets.pancreas.html Erythroid: https://scvelo.readthedocs.io/en/stable/scvelo.datasets.gastrulation_erythroid.html#scvelo.datasets.gastrulation_erythroid
5 comments
Q1. Thank you.
Q2. I see. This is quite affordable. I have two further questions.
- Is there any theoretical or empirical evidence that the path optimization is indeed solved? Or you just try your best to optimize it? (That's OK for me, since the optimization problem seems complicated.) I have read some article like https://arxiv.org/abs/2609.04710. They also tried to learned the interpolant and numerical integrated cost. They mentioned about the low dimensionality of the interpolant makes it capable to learn. However, in your paper, it feels like high dimensional interpolant is also OK to learn. They have reported the error between learned interpolant, cost and the true interpolant , cost on some cases. Can you also do some empirical check? I am very curious about whether high dimension brings difficulty to optimization.
2.116s, 277s seems larger than the total time reported in your table 2?
Q3. Thank you. But isn't 8 too small? 50 or 100 may sound better. Just a comment.
Q4, Q5. Ok, thank you.
W2. Amazing results, that's sufficient to me.
W1. I have major concern about this application setting!! A primary motivation of our method is to enable trajectory inference from single snapshot experiments. To the best of my knowledge, classical trajectory inference were developed to overcome the lack of true physical time. Nowadays, we can measure transcriptomics at different physical time, why should we go back to single snapshot?? I didn't understand.
Pseudotime is not time, it is not even a good analog to time. It is just something like a metric based on cell-cell similarity. I don't think it is proper to use pseudotime as labels. Also, velocity pesudotime, diffusion map based pseudotime, palantir, ……, all of these pseudotime methods were computed on all cells. This brings inevitable data leakage. And, dosn't pseudotime itself something like 'trajectory'? From this perspective, I seriously believe the real data experiments need to be conducted on more proper multi time point datasets.
Their benchmark does not use the embryonic stage labels, but pools the cells and splits them into three quantiles of latent time Like what I mentioned above, in my opinion, that's false.
Overall, I truely appreeciate the idea of introducing the Finsler metric. It is really elegant and promising. But I seriously doubt the experimental setting. If the authors can address W1, I will raise my score to 4, otherwise, I will change it to 1.
Part 1/2 We thank the reviewer for the quick and transparent follow-up, and for their encouraging comments regarding the Finsler construction.
Q2. To test how close we can get to solve this optimization problem we would propose to run and experiment on a sphere for and large enough, since there we have analytical solutions to geodesic. We will provide details once finished. Furthermore, the formulation for the runtime analysis might have been imprecise out of the number mentioned above 21/99/24s corresponding to the time spent on the geodesic optimization.
W1. We very much agree with the reviewer that the distinction of real time and pseudotime is important and we thank them for emphasizing it. Crucially, pseudotime partitions cannot be interpreted as independent temporal ground truth. We therefore also agree that real-data evaluation on experimental time points would greatly enhance the manuscript and we are running these experiments now:
-
Embryoid body differentiation (Moon et al., 2019): five experimental time points, with the leave-one-time-point-out protocol used by MFM (Kapusniak et al., 2024) and earlier work.
-
Mouse haematopoiesis, LARRY (Weinreb et al., 2020; days 2, 4 and 6): prediction of fate probabilities to compare different kernel constructions, including one derived from the experimental time points.
We will report these results as soon as they are complete. We will integrate them into the manuscript as the major component of the real data evaluation.
Furthermore, we already ran experiments on Mouse erythroid development (Pijuan-Sala et al., 2019) we highlight here the results in PCA d = 20. We evaluated a holdout of experimental time points, using embryonic-stage labels (E7.0–E8.5) instead of latent time. We define $ $using E7.0–E7.75 and using E8.5, withholding all intermediate-stage cells (E8.0 and E8.25). We compare either samples generated at or pooled samples from five equally spaced time points in against the withheld population.
\hline \text{Method} & t=1/2 & t\in[1/3,2/3] \\\\ \hline \text{Sampling floor} & 4.08 & 4.08 \\\\ \text{OT-CFM} & 6.72 & 6.66 \\\\ \text{MFM / LAND} & 5.70 & 5.62 \\\\ \text{Curly-FM} & 10.04 & 9.61 \\\\ \text{FFM (velocity)} & 6.39 & 6.40 \\\\ \text{FFM (expression)} & \mathbf{5.47} & \mathbf{5.57} \\\\ \hline \end{array}$$ We additionally performed a leave-one-out evaluation using actual embryonic stages. Each intermediate stage was withheld and predicted at $�4�$from E7.75 → E8.25, and from E8.0 → E8.5. $$\begin{array}{lcccc} \hline \text{Method} & \text{E8.0} & \text{E8.25} \\\\ \hline \text{Sampling floor} & 3.87 & 3.85 \\\\ \text{OT-CFM} & 5.76 & 5.54 \\\\ \text{MFM / LAND} & 5.88 & 5.32\\\\ \text{Curly-FM} & 7.50 & 7.36 \\\\ \text{FFM (velocity)} & 5.61 & 5.46 \\\\ \text{FFM (expression)} & \mathbf{5.59} & \mathbf{5.17} \\\\ \hline \end{array}$$
We thank the reviewer for the careful reading and constructive comments. We agree that several aspects require clarification.
Q1: Non-negativity of Eq. (9). By Cauchy–Schwarz, with A=Cρ−1,
FP(x,v)≥(∥m∥A2+λ2−∥m∥A)∥v∥A≥0.
Since λ>0 and C is positive definite, the inequality is strict v=0. We will state this explicitly in the manuscript.
Q2: Computational complexity of Eq. (11). On Pancreas, total deterministic FFM runtimes on a V100 are 26/116/277s for d = 2/20/50, respectively. The geodesic phase accounts for 78–86% of runtime.
Q3: Computation of the Finsler cost in Eq. (13). After training the geodesic interpolant, we evaluate the cost of each endpoint pair using numerical quadrature with 8 nodes along the learned path, followed by Sinkhorn iterations. We will add this clarification to the paper.
Q4: Divergence term in the SDE. The additional term arises from the state-dependent diffusion covariance. For a(t,x)=g(t)2Cρ(x), the Fokker–Planck equation requires the drift correction 21∇a in addition to 21a∇logpt to preserve the prescribed probability marginals. Since g depends only on time, this yields 21g(t)2divCρ(x). We will add the corresponding derivation to the manuscript and clarify its distinction from the state-independent case in Eq. (6).
Q5: Sampling floor. The sampling floor is the empirical W2 distance between two disjoint, subsets of the reference population. We will clarify its definition in the experimental section.
W1: Interpretation of temporal information in real-data experiments . We thank the reviewer for raising this point, we agree that this was not described with sufficient clarity in the manuscript. The reviewer is correct that all Pancreas cells were collected at a single time point (E15.5). This is in fact the setting that FFM was designed for. A primary motivation of our method is to enable trajectory inference from single snapshot experiments. Because differentiation is asynchronous, one snapshot can capture cells along the full trajectory and additional dynamical information, such as RNA velocity, provides the local directionality that would otherwise come from time labels. FFM leverages this information, encoded as a cell-cell transition kernel, to infer continuous trajectories within the snapshot. The values t = 0, 1/2, 1 in our experiments therefore do not denote experimental time points, but rather bins of a single snapshot along an inferred progression coordinate (tertiles of scVelo latent time for Pancreas, diffusion pseudotime for iTracer). The first and last tertiles serve as p0/p1 , the middle is withheld, and the model must reconstruct it from the endpoints and the dynamical information alone. This is the single-snapshot analogue of leave-one-time-point-out evaluation. For Erythroid, our setup directly follows CurlyFM (Petrović et al., 2025) to allow direct comparison. Their benchmark does not use the embryonic stage labels, but pools the cells and splits them into three quantiles of latent time, which is why our labels do not match the stages in the scVelo documentation. We will edit the manuscript to replace “temporal snapshots” with “pseudotime partitions” and add an appendix section describing the construction for each dataset.
W2: Potential RNA-velocity leakage. The reviewer is right and we thank the reviewer for identifying this important issue. The transition graph was recomputed without withheld cells, but the velocities had been estimated on all cells, which can lead to leakage into the test set. For this response we re-estimated velocity, including the scVelo moments, after excluding the withheld cells. We then repeated the experiments using these refitted velocities. Pancreas:
\hline d & \text{FFM (original/refit)} & \text{Curly-FM (original/refit)} & \text{MFM} & \text{OT-CFM} \\\\ \hline 2 & 1.40/1.60 & 0.95/1.54 & \mathbf{1.47} & 1.76 \\\\ 20 & 10.48/\mathbf{10.95} & 12.19/12.41 & 12.11 & 12.34 \\\\ 50 & 12.57/\mathbf{12.82} & 13.28/13.47 & 12.96 & 13.49 \\\\ \hline \end{array}$$ The results confirm that the original velocity estimates contained information from the withheld cells. Removing this information worsens both velocity-informed methods, particularly for CurlyFM in 2D. With refitted velocities, FFM retains the lowest mean midpoint W2 at d = 20 and 50. At d = 2, MFM becomes the best-performing method. For Erythroid, refitting velocity changes FFM's 2D midpoint W2 from 0.289 to 0.270, and Curly-FM from 0.158 to 0.226. At d = 20/50, all changes are at most 0.012. We will rerun all velocity-based experiments under this protocol and report the refitted values as the main results.